All Eyes on Gland Pharma: First-to-File Status Promises 180 Days of U.S. Market Dominance

Unknown Apr 02, 2026 750 Views

Gland Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%. This generic version is therapeutically equivalent to Bausch & Lomb’s Vyzulta and is indica...

Stay Ahead – Explore Now! Dhamaal 4 Release Date Validated: Film Hits Theatres July 10, 2026